Active energy ray-curable composition, cured product thereof, and optical adhesive sheet
By using inorganic oxide particles, (meth)acrylate and photopolymerization initiator compositions in optical adhesive sheets, the glass transition temperature of the hardened product is controlled, and the problems of high refractive index and good viscosity are solved, and the problem of high refractive index and good viscosity is achieved. Large optical adhesive sheet with high refractive index and flexibility.
Patent Information
- Application Number
- CN202410440791.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Priority Date
- 2023-05-23
- Filing Date
- 2024-04-12
- Publication Date
- 2024-11-26
AI Technical Summary
Compounds or inorganic particles with high refractive index in existing optical adhesive sheets may cause the glass transition temperature of the resin hardened substance to increase, thereby reducing viscosity and adhesion, making it difficult to achieve high refractive index and good viscosity at the same time.
A composition containing inorganic oxide particles, (meth)acrylate and a photopolymerization initiator is used, and the hardened glass transition temperature is controlled below -2°C to ensure high refractive index and good viscosity.
It realizes an optical adhesive sheet with high refractive index, softness and resilience after hardening, and is suitable for adhesive applications of display devices.
Smart Images

Figure CN119019598A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to an active energy ray-curable composition, a cured product thereof, and an optical adhesive sheet. Background Art
[0002] In recent years, in displays such as organic electroluminescence (EL) display devices, optical adhesive sheets are used to bond components such as glass cover plates or metal mesh films, polarizing plates, etc. Typically, such optical adhesive sheets are made by hardening a photocurable resin composition sandwiched in a release sheet. If the optical adhesive sheet has high light transmittance and a high refractive index, the refractive index difference with the component becomes smaller, so the light extraction efficiency is improved. In addition, from the perspective of reducing the amount of solvent used in the process and reducing the energy required for pre-baking, it is preferred that the material used in the optical adhesive sheet does not contain a solvent (for example, Patent Document 1).
[0003] On the other hand, a photocurable resin composition having a low viscosity and an increased refractive index even without the addition of a solvent, and a high-refractive resin cured body obtained by photocuring the photocurable resin composition are disclosed (for example, Patent Document 2). In order to increase the refractive index, a method of using a high-refractive index compound or adding inorganic high-refractive index particles is proposed.
[0004] [Prior art literature]
[0005] [Patent Document]
[0006] [Patent Document 1] Japanese Patent No. 7116545
[0007] [Patent Document 2] Japanese Patent Application Publication No. 2017-128688 Summary of the invention
[0008] [Problems to be solved by the invention]
[0009] However, compounds or inorganic particles with a high refractive index generally increase the glass transition temperature (Tg) of the cured resin, thereby deteriorating the viscosity and adhesion of the optical adhesive sheet. Therefore, a material with high refractive index and adhesiveness is required even after curing.
[0010] The present invention is made to solve the above-mentioned problems, and its purpose is to provide a high-refractive-index active energy ray-curable composition having adhesiveness even after curing, its cured product and optical adhesive sheet by making the Tg of the composition containing inorganic oxide particles, (meth)acrylate and photopolymerization initiator below -2°C after curing.
[0011] [Technical means to solve the problem]
[0012] The content of the present disclosure includes the following embodiments.
[0013] [1] An active energy ray-curable composition comprising inorganic oxide particles (A) and (meth)acrylate (B),
[0014] The active energy ray-curable composition has a refractive index of 1.6 or more,
[0015] The active energy ray-curable composition has a cured product having a glass transition temperature Tg of -2°C or less.
[0016] [2] The active energy ray-curable composition according to [1], further comprising a photopolymerization initiator (C).
[0017] [3] The active energy ray-curable composition according to [1] or [2], wherein the inorganic oxide particles (A) are zirconium oxide particles.
[0018] [4] The active energy ray-curable composition according to any one of [1] to [3], wherein the (meth)acrylate (B) contains a (meth)acrylate (B-1) having a polymer Tg of -2°C or less.
[0019] [5] The active energy ray-curable composition according to [4], wherein the (meth)acrylate (B) comprises at least two (meth)acrylates,
[0020] The two (meth)acrylates further include a (meth)acrylate (B-2) of a different kind from the (meth)acrylate (B-1).
[0021] [6] The active energy ray-curable composition according to any one of [1] to [5], further comprising a dispersant (D).
[0022] [7] The active energy ray-curable composition according to [6], wherein the dispersant (D) contains a phosphate compound.
[0023] [8] The active energy ray-curable composition according to any one of [1] to [7], wherein a cured product of the active energy ray-curable composition has a glass transition temperature Tg of -5°C or less.
[0024] [9] The active energy ray-curable composition according to any one of [1] to [8], wherein the active energy ray-curable composition is used for an optical adhesive sheet.
[0025]
[10] A cured product of the active energy ray-curable composition according to any one of [1] to [8], wherein the cured product has a glass transition temperature Tg of -2°C or less.
[0026]
[11] An optical adhesive sheet comprising the cured product according to
[10] .
[0027] [Effects of the Invention]
[0028] According to the present invention, there can be provided an active energy ray-curable composition having high tackiness even after curing, high flexibility, large restorability, and a high refractive index, and a cured product thereof and an optical adhesive sheet. BRIEF DESCRIPTION OF THE DRAWINGS
[0029] Figure 1 This is a cross-sectional view of an optical adhesive sheet (cured product) according to one embodiment of the present invention.
[0030] Figure 2 This is a simulation diagram for explaining the method of evaluating microhardness.
[0031] [Explanation of Symbols]
[0032] 1: Adhesive sheet (hardened material)
[0033] 2a, 2b: Peel-off sheet
[0034] F: Test force
[0035] Wplast: Plastic deformation work
[0036] Welast: elastic deformation work
[0037] h: Pressing depth
[0038] h1: The penetration depth when the maximum test force is reached
[0039] h2: The penetration depth after maintaining the maximum test force
[0040] hmax: maximum penetration depth DETAILED DESCRIPTION
[0041] Hereinafter, the present invention will be described in more detail. In addition, the present invention is not limited only to the embodiment shown below.
[0042] “To” means a value greater than or equal to the value before “to” and less than or equal to the value after “to”. “(Meth)acrylic acid” is a general term for acrylic acid and methacrylic acid, and “(meth)acrylate compound (B)” is a general term for acrylate compounds and methacrylate compounds.
[0043] (Active energy ray-curable composition)
[0044] The active energy ray-curable composition of this embodiment contains inorganic oxide particles (A) and a (meth)acrylate compound (B). The refractive index of the active energy ray-curable composition is 1.6 or more. The glass transition temperature Tg of the cured product of the active energy ray-curable composition is -2°C or less. The active energy ray-curable composition of this embodiment preferably further contains a photopolymerization initiator (C).
[0045] [Inorganic oxide particles (A)]
[0046] The inorganic oxide particles (A) of the present embodiment are preferably at least one selected from the group consisting of zirconium oxide, silicon dioxide, barium sulfate, zinc oxide, barium titanate, cerium oxide, aluminum oxide, and titanium oxide. The inorganic oxide particles (A) of the present embodiment are preferably zirconium oxide particles.
[0047] The crystal structure of the inorganic oxide particles (A) of the present embodiment is not particularly limited. For example, in the case of zirconium oxide particles, a monoclinic system is preferred in terms of excellent dispersion stability and the ability to obtain a cured product with high light transmittance and refractive index.
[0048] The inorganic oxide particles (A) of this embodiment can generally use known particles, and the shape of the particles is not particularly limited, and can be any of spherical, hollow, porous, rod-shaped, plate-shaped, fibrous or amorphous. Among them, spherical particles are preferred in terms of excellent dispersion stability and the ability to obtain a cured product with high light transmittance and refractive index.
[0049] <Zirconium oxide nanoparticles>
[0050] The inorganic oxide particles (A) of this embodiment are more preferably zirconium oxide nanoparticles. The zirconium oxide nanoparticles may be generally known particles, and the particle shape is not particularly limited, and examples thereof include spherical, hollow, porous, rod-shaped, and fibrous particles, among which spherical particles are preferred.
[0051] The average primary particle diameter of the zirconium oxide nanoparticles of the present embodiment is preferably 1 nm to 50 nm, and more preferably 1 nm to 30 nm. Furthermore, the crystal structure is not particularly limited, but is preferably a monoclinic system.
[0052] In addition, the average primary particle diameter in the present invention can be measured by the following method: using a transmission electron microscope (TEM), the size of the primary particles is directly measured based on the electron microscope photograph. As a measuring method, for example, the minor axis diameter and major axis diameter of the primary particles of each inorganic particle are measured, and the average value is used as the average primary particle diameter of the primary particles.
[0053] Specific examples of the zirconium oxide nanoparticles of the present embodiment include UEP-100 manufactured by Daiichi Kokino Kagaku Kogyo Co., Ltd. (average primary particle diameter: 11 nm) and PCS manufactured by Nippon Denko KK (average primary particle diameter: 20 nm).
[0054] [(Meth)acrylate compound (B)]
[0055] The (meth)acrylate compound (B) of this embodiment is not particularly limited as long as the refractive index of the active energy ray-curable composition prepared using the (meth)acrylate compound (B) is 1.6 or more, and the glass transition temperature Tg of the cured product of the active energy ray-curable composition is -2°C or less. The refractive index may be 1.62 or more, or 1.64 or more. In addition, the refractive index may be 1.69 or less. The glass transition temperature Tg may be -4°C or less, or -9°C or less.
[0056] As the (meth)acrylate compound (B) of the present embodiment, for example, monofunctional (meth)acrylate and multifunctional (meth)acrylate can be cited. In the (meth)acrylate compound (B), it is preferred to contain more than 70% by mass of monofunctional (meth)acrylate, more preferably more than 90% by mass, and may also contain 100% by mass. For example, monofunctional (meth)acrylate or multifunctional (meth)acrylate with (meth)acryloyl group or (meth)acryloyloxy group for forming an existing known optical sheet can be cited. Oligomers or prepolymers can be used as needed.
[0057] The monofunctional (meth)acrylate is a monofunctional (meth)acrylate having one active energy ray-curable group, and the polyfunctional (meth)acrylate is a polyfunctional (meth)acrylate having two or more active energy ray-curable groups.
[0058] The (meth)acrylate compound (B) of the present embodiment does not contain a dispersant (D) having a (meth)acryloyl group and a silane coupling agent (E) having a (meth)acryloyl group or a (meth)acryloyloxy group, which will be described later.
[0059] The (meth)acrylate (B) preferably includes a (meth)acrylate (B-1) having a polymer Tg of -2°C or less. By using a (meth)acrylate (B-1) having a polymer Tg of -2°C or less, it is easy to prepare an active energy ray-curable composition having a glass transition temperature Tg of a cured product of -2°C or less. The polymer Tg may be -4°C or less, -5°C or less, or -10°C or less. In addition, it may be -150°C or more, or -100°C or more.
[0060] In the present invention, the "polymer Tg" of a monomer compound is the Tg (glass transition temperature) of the polymer of the monomer compound, which indicates the temperature at the boundary of the glass state to the rubber state when the resin is heated. Tg can be measured by differential scanning calorimeter (DSC), dynamic viscoelasticity measurement (dynamic mechanical analysis (DMA)), thermomechanical analysis (TMA), etc.
[0061] Regarding the Tg of the cured product of the composition, that is, the Tg of the copolymer of multiple monomers, the more monomers with low homopolymer Tg are included, the lower the Tg is. For example, theoretically, the Tg of a copolymer of monomer M including monomer 1, monomer 2, ... monomer n can be calculated using the following Fox equation.
[0062] [Number 1]
[0063]
[0064] (Tg: glass transition temperature of copolymer (unit: Kelvin K), C1: weight fraction of monomer 1, Tg1: glass transition temperature of homopolymer of monomer 1)
[0065] However, since Tg may also change due to the influence of polymerization conditions, reaction rate, molecular weight, crosslinking point, and filler, it is difficult to predict the Tg of a composition containing nano inorganic particles such as the present invention based on the homopolymer Tg of each monomer. For example, in Example 3 described later, 2.9 parts by mass of monomer 1 (Tg1 = -32°C) and 24.3 parts by mass of monomer 2 (Tg2 = 8°C) are used. The theoretical value of Tg of the copolymer of monomer 1 and monomer 2 calculated by the Fox formula is 3°C. However, as shown in Table 1, in the case of containing 53.6 parts by mass of inorganic particles, the measured value of Tg of the cured product of Example 1 is -4°C.
[0066] The content of the (meth)acrylate (B-1) in the (meth)acrylate (B) of the present embodiment is preferably 2% by mass or more, more preferably 5% by mass or more, and even more preferably 10% by mass or more. In addition, the upper limit of the content of the (meth)acrylate (B-1) is not particularly limited, and the higher the value, the more preferred. If an example must be given, from the perspective of balance with the refractive index, it is more preferably 90% by mass or less, and even more preferably 80% by mass or less.
[0067] The content of the (meth)acrylate (B-1) in the active energy ray-curable composition of the present embodiment is preferably 0.5% by mass or more, more preferably 1% by mass or more, and even more preferably 2% by mass or more. In addition, the content of the (meth)acrylate (B-1) is preferably 50% by mass or less, more preferably 40% by mass or less, and even more preferably 30% by mass or less.
[0068] The (meth)acrylate (B) includes at least two (meth)acrylates, and the two (meth)acrylates may further include a (meth)acrylate (B-2) different from the (meth)acrylate (B-1). The (meth)acrylate (B-2) is preferably a (meth)acrylate having a polymer Tg of 0°C or higher. The polymer Tg may be 5°C or higher, or 10°C or higher. In addition, the polymer Tg may be 50°C or lower.
[0069] The content of the (meth)acrylate (B-2) in the (meth)acrylate (B) of the present embodiment is preferably 10% by mass or more, more preferably 15% by mass or more, and even more preferably 30% by mass or more. In addition, the content of the (meth)acrylate (B-2) is preferably 95% by mass or less, and even more preferably 90% by mass or less.
[0070] The content of the (meth)acrylate (B) in the active energy ray-curable composition of the present embodiment is preferably 10% by mass or more, more preferably 15% by mass or more, and even more preferably 20% by mass or more. In addition, the content of the (meth)acrylate (B-1) is preferably 60% by mass or less, more preferably 50% by mass or less, and even more preferably 40% by mass or less.
[0071] <Monofunctional (meth)acrylate>
[0072] The monofunctional (meth)acrylate is a monofunctional (meth)acrylate having one active energy ray-curable group, and may be a chain aliphatic or cyclic alicyclic or aromatic (meth)acrylate containing heteroatoms such as halogen atoms, sulfur atoms, oxygen atoms or nitrogen atoms.
[0073] Examples of the monofunctional (meth)acrylate include aromatic mono(meth)acrylate compounds, aliphatic mono(meth)acrylate compounds, alicyclic mono(meth)acrylate compounds, heterocyclic mono(meth)acrylate compounds, and hydroxyl-containing mono(meth)acrylate compounds.
[0074] In addition, examples of the monofunctional (meth)acrylate include: polyoxyalkylene-modified mono(meth)acrylate compounds obtained by introducing polyoxyalkylene chains such as polyoxyethylene chains, polyoxypropylene chains, and polyoxytetramethylene chains into the molecular structures of the various mono(meth)acrylate compounds; lactone-modified mono(meth)acrylate compounds obtained by introducing a (poly)lactone-derived structure into the molecular structures of the various mono(meth)acrylate compounds; and the like.
[0075] Examples of the aromatic mono(meth)acrylate compound include benzyl(meth)acrylate, phenyl(meth)acrylate, phenoxy(meth)acrylate, phenoxyethyl(meth)acrylate, phenoxyethoxyethyl(meth)acrylate, 2-hydroxy-3-phenoxypropyl(meth)acrylate, phenoxybenzyl(meth)acrylate, biphenylmethyl(meth)acrylate, benzylbenzyl(meth)acrylate, phenylphenoxyethyl(meth)acrylate, phenylphenol(ethylene oxide (EO))n(meth)acrylate, and phenol(EO)n(meth)acrylate.
[0076] Examples of the aliphatic mono(meth)acrylate compound include methyl(meth)acrylate, ethyl(meth)acrylate, propyl(meth)acrylate, n-butyl(meth)acrylate, isobutyl(meth)acrylate, tert-butyl(meth)acrylate, n-pentyl(meth)acrylate, n-hexyl(meth)acrylate, n-octyl(meth)acrylate, isooctyl(meth)acrylate, and 2-ethylhexyl(meth)acrylate.
[0077] Examples of the alicyclic mono(meth)acrylate compound include cyclohexyl(meth)acrylate, isobornyl(meth)acrylate, adamantyl mono(meth)acrylate, cyclohexylmethyl(meth)acrylate, cyclohexylethyl(meth)acrylate, dicyclopentanyl(meth)acrylate, dicyclopentyloxyethyl(meth)acrylate, dicyclopentenyl(meth)acrylate, and dicyclopentenyloxyethyl(meth)acrylate.
[0078] Examples of the heterocyclic mono(meth)acrylate compound include glycidyl(meth)acrylate and tetrahydrofurfuryl acrylate.
[0079] Examples of the hydroxyl group-containing mono(meth)acrylate compound include hydroxyethyl(meth)acrylate, hydroxypropyl(meth)acrylate, and hydroxybutyl(meth)acrylate.
[0080] Examples of the lactone-modified mono(meth)acrylate compound include caprolactone-modified tetrahydrofurfuryl (meth)acrylate.
[0081] The monofunctional (meth)acrylates may be used alone or in combination of two or more.
[0082] The content of the monofunctional (meth)acrylate in the (meth)acrylate compound (B) is 70% by mass, preferably 75% by mass or more, more preferably 80% by mass or more, and further preferably 85% by mass or more. In addition, it is preferably 95% by mass or less, and more preferably 90% by mass or less. This is because when the content of the monofunctional (meth)acrylate is within the above range, the refractive index is high and the viscosity is low.
[0083] [(Meth)acrylate (B-1)]
[0084] The (meth)acrylate (B-1) having a polymer Tg of -2°C or less is preferably a monofunctional (meth)acrylate. When the (meth)acrylate (B-1) is a monofunctional (meth)acrylate, examples of the (meth)acrylate (B-1) include those having a polymer Tg of -2°C or less among the monofunctional (meth)acrylates described above. Examples include n-butyl (meth)acrylate, hydroxyethyl (meth)acrylate, hydroxypropyl (meth)acrylate, hydroxybutyl (meth)acrylate, lauryl (meth)acrylate, isodecyl (meth)acrylate, and tetrahydrofurfuryl (meth)acrylate. Specific examples of the (meth)acrylate (B-1) include EO-modified phenoxyethyl acrylate (n=4) (polymer Tg=-32°C) and 2-ethylhexyl acrylate (polymer Tg=-70°C).
[0085] [(Meth)acrylate (B-2)]
[0086] The (meth)acrylate (B-2) is preferably a monofunctional (meth)acrylate having a polymer Tg of 0°C or more. It is preferably an aromatic mono(meth)acrylate compound, and more preferably a compound having two aromatic rings in one molecule. In this case, as (meth)acrylate (B-2), for example, there can be listed: those having a polymer Tg of 0°C or more among the monofunctional (meth)acrylates described above. For example, there can be listed: benzyl (meth)acrylate, phenyl (meth)acrylate, phenoxy (meth)acrylate, and phenoxyethyl (meth)acrylate. As a specific example of (meth)acrylate (B-2), there can be listed phenoxybenzyl acrylate (polymer Tg = 8°C).
[0087] [Multifunctional (meth)acrylate]
[0088] The (meth)acrylate compound (B) of the present embodiment may contain a polyfunctional (meth)acrylate or not, in addition to the monofunctional (meth)acrylate of the present embodiment.
[0089] The polyfunctional (meth)acrylate is preferably a polyfunctional (meth)acrylate having three or more active energy ray-curable groups, and may be a chain aliphatic or cyclic alicyclic or aromatic (meth)acrylate containing heteroatoms such as halogen atoms, sulfur atoms, oxygen atoms or nitrogen atoms.
[0090] Examples of the polyfunctional (meth)acrylate include ethylene glycol di(meth)acrylate, diethylene glycol di(meth)acrylate, triethylene glycol di(meth)acrylate, polyethylene glycol di(meth)acrylate, propylene glycol di(meth)acrylate, dipropylene glycol di(meth)acrylate, tripropylene glycol di(meth)acrylate, butanediol di(meth)acrylate, tetrabutanediol di(meth)acrylate, 1,4-butanediol di(meth)acrylate, and 1,6-hexanediol di(meth)acrylate. Alcohol di(meth)acrylate, 1,9-nonanediol di(meth)acrylate, neopentyl glycol di(meth)acrylate, dicyclopentyl di(meth)acrylate, glycerol di(meth)acrylate, neopentyl glycol hydroxypivalate di(meth)acrylate, caprolactone-modified hydroxypivalate neopentyl glycol di(meth)acrylate, tetrabromobisphenol A di(meth)acrylate, hydrogen pivalaldehyde-modified trimethylolpropane di(meth)acrylate, bisphenol fluorene di(meth)acrylate, bisphenol fluorene (EO) n Di(meth)acrylate, bisphenol A (EO) n Di(meth)acrylate, trimethylolpropane (EO) n Polyfunctional (meth)acrylates (B2) such as tri(meth)acrylate, 1,4-cyclohexanedimethanol di(meth)acrylate, trimethylolpropane tri(meth)acrylate, pentaerythritol tri(meth)acrylate, glycerol tri(meth)acrylate, alkyl-modified dipentaerythritol tri(meth)acrylate, pentaerythritol tetraacrylate, di-trimethylolpropane tetra(meth)acrylate, epoxy (meth)acrylate, urethane (meth)acrylate and polyester (meth)acrylate.
[0091] These multifunctional (meth)acrylates may be used alone or in combination of two or more. Among these, trimethylolpropane tri(meth)acrylate, ethoxylated trimethylolpropane tri(meth)acrylate, di-trimethylolpropane tetra(meth)acrylate, a reaction product of pentaerythritol and acrylic acid, a reaction product of dipentaerythritol and acrylic acid, etc. are preferred in terms of obtaining a (meth)acrylic resin that is excellent in drying properties, ink fluidity, and high-speed printing.
[0092] [Photopolymerization initiator (C)]
[0093] The photopolymerization initiator (C) of the present embodiment is not particularly limited as long as it has the function of starting polymerization of the (meth)acryloyl group of the (meth)acrylate compound (B) of the present embodiment by light excitation, and examples thereof include intramolecular bond cleavage type photopolymerization initiators (C), intramolecular hydrogen abstraction type photopolymerization initiators (C), etc. For example, monocarbonyl compounds, dicarbonyl compounds, acetophenone compounds, benzoin ether compounds, acylphosphine oxide compounds, aminocarbonyl compounds, etc. can be used.
[0094] Examples of the intramolecular bond cleavage type photopolymerization initiator (C) include acetophenone-based initiators such as diethoxyacetophenone, 2-hydroxy-2-methyl-1-phenylpropane-1-one, benzyl dimethyl ketal, 1-(4-isopropylphenyl)-2-hydroxy-2-methylpropane-1-one, 4-(2-hydroxyethoxy)phenyl-(2-hydroxy-2-propyl)ketone, 1-hydroxycyclohexyl-phenyl ketone, 2-methyl-2-morpholino (4-methylthiophenyl)propane-1-one, and 2-benzyl-2-dimethylamino-1-(4-morpholinophenyl)-butanone; benzoins such as benzoin, benzoin methyl ether, and benzoin isopropyl ether; acylphosphine oxide-based initiators such as 2,4,6-trimethylbenzoyldiphenylphosphine oxide; benzyl and methyl benzoylformate;
[0095] Examples of the intramolecular hydrogen abstraction type photopolymerization initiator (C) include benzophenone, methyl o-benzoylbenzoate, 4-phenylbenzophenone, 4,4'-dichlorobenzophenone, hydroxybenzophenone, 4-benzoyl-4'-methyl-diphenyl sulfide, acrylated benzophenone, 3,3',4,4'-tetra(tert-butylperoxycarbonyl)benzophenone, 3,3'-dimethyl-4-methoxybenzophenone and the like; thioxanthone such as 2-isopropylthioxanthone, 2,4-dimethylthioxanthone, 2,4-diethylthioxanthone, 2,4-dichlorothioxanthone and the like; aminobenzophenone such as Michler's ketone and 4,4'-diethylaminobenzophenone; 10-butyl-2-chloroacridone, 2-ethylanthraquinone, 9,10-phenanthrenequinone, camphorquinone and the like.
[0096] The photopolymerization initiator (C) is preferably 2,4,6-trimethylbenzoyldiphenylphosphine oxide.
[0097] Commercially available products of the photopolymerization initiator (C) include Omnirad-184, Omnirad-651, Omnirad-500, Omnirad-907, Omnirad-127, Omnirad-369, Omnirad-784, Omnirad-2959, and Omnirad-TPO-H manufactured by IGM-Resins; and Esacure ONE manufactured by DKSH Co., Ltd. of Japan.
[0098] Omnirad-907 and Omnirad-TPO-H are preferred from the viewpoint of obtaining a cured coating film having excellent curability even when added in a small amount, and Omnirad-184 is particularly preferred from the viewpoint of less coloration.
[0099] The photopolymerization initiator (C) is not limited to the above compounds, and may be any compound as long as it has the ability to initiate polymerization by ultraviolet rays. These photopolymerization initiators (C) may be used alone or in combination of two or more.
[0100] The amount of the photopolymerization initiator (C) used is not particularly limited, but is preferably used in a range of 0.1 to 10 parts by mass, more preferably in a range of 1 to 5 parts by mass, relative to 100 parts by mass of the total non-volatile components of the active energy ray-curable composition of this embodiment. As a sensitizer, a known organic amine or the like may also be added.
[0101] Furthermore, in addition to the above-mentioned radical polymerization initiator, an initiator for cationic polymerization may be used in combination.
[0102] As a specific example of the photopolymerization initiator (C) of this embodiment, for example, Runtecure 1108 (manufactured by Runtec Chemical Co., Ltd., structural formula or compound name: 2,4,6-trimethylbenzoyldiphenylphosphine oxide)
[0103] The content of the photopolymerization initiator (C) is preferably 0.1% by mass to 10% by mass, more preferably 0.5% by mass to 5% by mass, based on the mass of the non-volatile components of the composition.
[0104] The nonvolatile content of the composition refers to the total weight of all components of the composition excluding the solvent contained in the composition.
[0105] [Dispersant (D)]
[0106] The active energy ray-curable composition of the present embodiment preferably further contains a dispersant (D), and more preferably the dispersant (D) contains a phosphoric acid ester.
[0107] <Phosphate ester>
[0108] The phosphoric acid ester in the present embodiment is not particularly limited, and examples thereof include phosphoric acid esters having a polyester chain and phosphoric acid esters having a (meth)acryloyl group.
[0109] Examples of the phosphate ester having a polyester chain include DISPERBYK-110 and DISPERBYK-111 (manufactured by BYK-Chemie Japan Co., Ltd.).
[0110] In addition, as a phosphate ester having a (meth)acryloyl group, for example, a phosphate ester represented by the following structural formula (1) can be cited in terms of the fact that the obtained inorganic particle dispersion has excellent dispersion stability, the curable composition containing the phosphate ester has a low viscosity, and a hardened coating film having a high refractive index performance and excellent bleed resistance can be formed.
[0111] [Chemistry 1]
[0112]
[0113] (Where R 1 is a hydrogen atom or a methyl group, R 2 is an alkylene chain having 2 to 4 carbon atoms; in addition, x is an integer of 4 to 10, y is an integer greater than 1, and n is an integer of 1 to 3)
[0114] Regarding the phosphate compound represented by the structural formula (1), in terms of the obtained active energy ray-curable composition having low viscosity and being able to form a cured coating film having high refractive index performance and excellent bleed resistance, x in the formula is preferably 4 or 5, and y is preferably an integer of 2 to 7. In addition, the dispersant (D) represented by the structural formula (1) may be a mixture in which n in the formula is 1, 2 and / or 3.
[0115] The content of the phosphate compound in the active energy ray-curable composition is preferably in the range of 5 to 40 parts by mass, and further preferably in the range of 10 to 25 parts by mass, relative to 100 parts by mass of zirconium oxide, in terms of forming a cured coating having high refractive index performance and excellent bleed resistance.
[0116] [Silane coupling agent (E)]
[0117] The active energy ray-curable composition of the present embodiment may further include a silane coupling agent (E). Examples of the silane coupling agent (E) of the present embodiment include (meth)acryloyloxy-based silane coupling agents such as 3-(meth)acryloyloxypropyltrimethylsilane, 3-(meth)acryloyloxypropylmethyldimethoxysilane, 3-(meth)acryloyloxypropyltrimethoxysilane, 3-(meth)acryloyloxypropylmethyldiethoxysilane, and 3-(meth)acryloyloxypropyltriethoxysilane;
[0118] Vinyl silane coupling agents such as allyltrichlorosilane, allyltriethoxysilane, allyltrimethoxysilane, diethoxymethylvinylsilane, trichlorovinylsilane, vinyltrichlorosilane, vinyltrimethoxysilane, vinyltriethoxysilane, and vinyltri(2-methoxyethoxy)silane;
[0119] Epoxy silane coupling agents such as diethoxy(glycidoxypropyl)methylsilane, 2-(3,4-epoxycyclohexyl)ethyltrimethoxysilane, 3-glycidoxypropyltrimethoxysilane, 3-glycidoxypropylmethyldiethoxysilane, and 3-glycidoxypropyltriethoxysilane;
[0120] Styrene-based silane coupling agents such as p-styryltrimethoxysilane;
[0121] Amino silane coupling agents such as N-2-(aminoethyl)-3-aminopropylmethyldimethoxysilane, N-2-(aminoethyl)-3-aminopropyltrimethoxysilane, N-2-(aminoethyl)-3-aminopropyltriethoxysilane, 3-aminopropyltrimethoxysilane, 3-aminopropyltriethoxysilane, 3-triethoxysilyl-N-(1,3-dimethyl-butylene)propylamine, and N-phenyl-3-aminopropyltrimethoxysilane;
[0122] Urea-based silane coupling agents such as 3-ureidopropyltriethoxysilane;
[0123] Chloropropyl silane coupling agents such as 3-chloropropyltrimethoxysilane;
[0124] Mercapto-based silane coupling agents such as 3-mercaptopropylmethyldimethoxysilane and 3-mercaptopropyltrimethoxysilane;
[0125] Sulfide silane coupling agents such as bis(triethoxysilylpropyl)tetrasulfide;
[0126] Isocyanate-based silane coupling agents such as 3-isocyanatepropyltriethoxysilane;
[0127] Aluminum-based silane coupling agents such as acetoalkoxy aluminum diisopropionate, etc.
[0128] The silane coupling agent (E) of the present embodiment is preferably a (meth)acryloyloxy-based silane coupling agent such as 3-(meth)acryloyloxypropyltrimethoxysilane. Specific examples of 3-(meth)acryloyloxypropyltrimethoxysilane include methacryloyl group-containing silane coupling agent KBM-503 (manufactured by Shin-Etsu Silicone).
[0129] These silane coupling agents (E) may be used alone or in combination of two or more thereof. Among these, 3-(meth)acryloyloxypropyltrimethoxysilane is preferred because of its good compatibility with the acrylate compound (B).
[0130] The amount of the silane coupling agent (E) used in the present embodiment is preferably in the range of 10 to 30 parts by mass relative to 100 parts by mass of zirconium oxide, from the viewpoint that the obtained active energy ray-curable composition has excellent dispersion stability, has low viscosity, and can form a cured coating film having high refractive index performance and excellent bleed resistance.
[0131] [additive]
[0132] In the active energy ray-curable composition of the present embodiment, in addition to the above-mentioned components, various additives may be used at any stage of the production process within the range not departing from the purpose of the present invention.
[0133] As the additive, for example, known additives such as foam stabilizers, antioxidants, defoamers, fillers, pigments, dyes, colorants, tackifiers, surfactants, flame retardants, plasticizers, lubricants, antistatic agents, heat stabilizers, adhesion agents, curing catalysts, stabilizers, waxes, etc. can be used. In addition, as required, as a mixed resin, existing known thermoplastic resins, thermosetting resins, etc. can be appropriately selected and used within the scope that does not hinder the purpose of the present invention. In addition, the additive is just an example, and its type and usage are not particularly limited as long as it does not hinder the purpose of the present invention.
[0134] Specific examples of the plasticizer include dioctylphthalate (DOP), dibutylphthalate (DBP); dioctyl adipate, isodecyl succinate; diethylene glycol dibenzoate, pentaerythritol ester; butyl oleate, methyl acetylic ricinoleate; tricresyl phosphate, trioctyl phosphate; propylene glycol adipate polyester, butylene glycol adipate polyester, etc. These may be used alone or in combination of two or more.
[0135] [Solvent]
[0136] The active energy ray-curable composition of the present embodiment may contain a solvent.
[0137] As solvent, there is no particular limitation, and various known organic solvents can be used. Specifically, for example, cyclohexanone, methyl isobutyl ketone, methyl ethyl ketone, acetone, acetylacetone, toluene, xylene, n-butanol, isobutyl alcohol, tert-butanol, n-propanol, isopropyl alcohol, ethanol, methanol, 3-methoxy-1-butanol, 3-methoxy-2-butanol, ethylene glycol monomethyl ether, ethylene glycol mono-n-butyl ether, 2-ethoxyethanol, 1-methoxy-2-propanol, diacetone alcohol, ethyl lactate, butyl lactate, propylene glycol monomethyl ether, ethylene glycol monobutyl ether acetate, propylene glycol monomethyl ether acetate, 2-ethoxyethyl acetate, butyl acetate, isopentyl acetate, dimethyl adipate, dimethyl succinate, dimethyl glutarate, tetrahydrofuran, methyl pyrrolidone, etc. Among these, methyl ethyl ketone is preferred. These organic solvents can also be used in combination of two or more.
[0138] The active energy ray-curable composition of the present embodiment may contain, for example, a solvent used when synthesizing each resin.
[0139] The active energy ray-curable composition of the present embodiment may be prepared by mixing the inorganic oxide particles (A), a solvent, and any components to prepare a dispersion of the inorganic oxide particles (A), and then mixed with the (meth)acrylate compound (B) and, if necessary, the photopolymerization initiator (C).
[0140] The example of containing the solvent is an example, and even if the solvent is contained in the process of preparing the active energy ray-curable composition of this embodiment, it is preferable to volatilize the solvent in the end and reduce the content of the solvent as much as possible. Therefore, when the active energy ray-curable composition of this embodiment contains a solvent, the content of the solvent in the active energy ray-curable composition is preferably 0 mass % to 5 mass %, and more preferably 0 mass % to 0.1 mass %.
[0141] [Viscosity of Active Energy Ray-Curing Composition]
[0142] The active energy ray-curable composition of this embodiment preferably has a viscosity at 25° C. of 50,000 mPa·s or less, more preferably 15,000 mPa·s or less, and further preferably 6,000 mPa·s or less. Alternatively, it may be 1,000 mPa·s or more. As long as it is within the above range, the composition has film-forming suitability.
[0143] [Method for preparing active energy ray-curable composition]
[0144] The method for preparing the active energy ray-curable composition of the present embodiment is not particularly limited. For example, a method of preparing the composition by mixing the dispersion of the inorganic oxide particles (A), the (meth)acrylate (B), the photoinitiator (C), and other various additives as required after obtaining the dispersion of the inorganic oxide particles (A) is mentioned.
[0145] In addition, when commercially available inorganic oxide particles (A) are used, the method for producing the active energy ray-curable composition of the present embodiment may include a method of mixing a dispersion of the inorganic oxide particles (A), the (meth)acrylate (B), the photoinitiator (C), and various other additives as needed.
[0146] The method for manufacturing the active energy ray-curable composition of the present embodiment preferably includes: a step of preparing an inorganic oxide particle (A) dispersion; and a step of mixing the inorganic oxide particle (A) dispersion, the (meth)acrylate (B), a photoinitiator (C), and various other additives as needed.
[0147] The mixing method is not particularly limited, and an example thereof includes a method using a media-type wet disperser.
[0148] In the step of preparing the inorganic oxide particle (A) dispersion, at least a portion of the monofunctional (meth)acrylate or, if necessary, at least a portion of the polyfunctional (meth)acrylate (B2) may be added.
[0149] <Inorganic oxide particle (A) dispersion>
[0150] The inorganic oxide particle (A) dispersion of this embodiment preferably includes, for example, the inorganic oxide particles (A), the solvent, and the dispersant (D) as the additive. The inorganic oxide particle (A) dispersion of this embodiment may further include at least a portion of the (meth)acrylate (B).
[0151] The acid value of the dispersant (D) may be in the range of 50 mgKOH / g to 300 mgKOH / g. Generally speaking, the dispersant (D) is prone to inorganic nano-agglomeration in the system due to the interaction between the inorganic oxide particles (A) and other resin components contained in the active energy ray curable composition of this embodiment, etc., which reduces the stability of the active energy ray curable composition or reduces the transparency of the cured coating. By using a dispersant (D) with an acid value in the range of 50 mgKOH / g to 300 mgKOH / g, a curable composition with excellent stability over time can be obtained, and the cured product not only has a high refractive index, but also has excellent light transmittance or scratch resistance.
[0152] The inorganic oxide particle (A) dispersion of the present embodiment preferably further contains the silane coupling agent (E) as the additive. Functional groups can be introduced onto the surface of the inorganic oxide particle (A) using the various silane coupling agents (E) and the like.
[0153] The method for producing the inorganic oxide particle (A) dispersion of the present embodiment is not particularly limited, and examples thereof include a method of producing the dispersion by dispersing a raw material comprising the inorganic oxide particles (A), the dispersant (D), and, if necessary, the silane coupling agent (E) by a medium-type wet disperser.
[0154] The media-type wet disperser used in the production method can use any commonly known disperser without limitation, and examples thereof include a bead mill (Star Mill LMZ-015 manufactured by Ashizawa Finetech Co., Ltd., Ultra Apex Mill UAM-015 manufactured by Kotobuki Industry Co., Ltd., etc.).
[0155] The medium used in the disperser is not particularly limited as long as it is a commonly known bead, and preferably includes: zirconium oxide, aluminum oxide, silicon dioxide, glass, silicon carbide, silicon nitride. The average particle size of the medium is preferably 50 μm to 500 μm, and more preferably a medium of 50 μm to 200 μm. If the particle size is 50 μm or more, the impact force on the raw material powder is appropriate, and too much time is not required for dispersion. On the other hand, if the particle size of the medium is 500 μm or less, the impact force on the raw material powder is appropriate, so the increase in the surface energy of the dispersed particles can be suppressed, thereby preventing re-agglomeration.
[0156] Alternatively, the dispersion step time can be shortened by a two-stage method of using a large-diameter medium with a strong impact force in the initial stage of pulverizing the raw material powder and using a small-diameter medium that is less likely to re-agglomerate after the dispersed particles have become smaller in size.
[0157] Furthermore, from the viewpoint of suppressing a decrease in the light transmittance of the obtained dispersion, it is desirable to use a sufficiently ground medium.
[0158] In the production method using the media-type wet disperser, the order of charging the raw materials into the disperser is not particularly limited, but by supplying at least the dispersant (D) last, a curable composition with excellent dispersion stability can be obtained using a small amount of the dispersant (D). More specifically, there can be mentioned a method in which the raw materials other than the dispersant (D) are first charged, mixed or pre-dispersed, and then the dispersant (D) is charged last to perform the main dispersion process.
[0159] After dispersion is completed, various additives may be added according to the intended use, or volatile components may be removed by distillation, thereby obtaining the curable composition of the present invention.
[0160] In addition, regarding the particle size (set as the average particle size) of the inorganic oxide particles (A) in the inorganic oxide particle (A) dispersion, since a part of the inorganic oxide particles (A) are aggregated in the dispersion, it is larger than the average primary particle size of the inorganic oxide particles (A) which are the raw materials of the inorganic oxide particle (A) dispersion.
[0161] Therefore, in order to obtain a cured product having a high refractive index and excellent light transmittance, the average particle diameter of the inorganic oxide particles (A) in the inorganic oxide particle (A) dispersion is preferably 100 nm or less, more preferably in the range of 20 nm to 100 nm.
[0162] [Characteristics of Active Energy Ray-Curing Composition]
[0163] The refractive index of the active energy ray-curable composition of the present embodiment is 1.6 or more, may be 1.62 or more, may be 1.64 or more, and may be 1.69 or less.
[0164] The glass transition temperature Tg of the cured product of the active energy ray-curable composition of the present embodiment is -2°C or lower. It may be -4°C or lower, or -9°C or lower. It may be -50°C or higher.
[0165] (hardened material)
[0166] The hardened material of this embodiment is a hardened material of the active energy ray-curable composition of this embodiment. The hardened material of this embodiment can be used for various purposes such as optical parts such as optical lenses, optical films, anti-reflection materials, film sealing materials, optical adhesives, optical adhesives, diffusion microlenses, optical adhesive sheets (adhesive sheets for bonding display device components), etc.
[0167] The shape of the cured product of this embodiment is not particularly limited, and can be selected according to the application, such as a flat sheet with a smooth surface, a sheet with a fine concavoconvex structure, or a sheet with a curved surface like a concave lens or a convex lens.
[0168] In terms of being able to be thinned when used in an optical lens, or reducing the refractive index difference with a transparent electrode in an optical film to make the transparent electrode inconspicuous, or imparting an anti-reflection function by combining with a low refractive index layer, or improving the light extraction efficiency from the light-emitting element part in a light-emitting diode (LED) sealing material, the refractive index (589nm) of the cured product of this embodiment at 25°C is preferably 1.62 or more, more preferably 1.65 or more, and even more preferably 1.66 or more. In addition, the upper limit of the refractive index is not particularly limited, and the higher the value, the more preferred. If an example must be given, from the perspective of balance with viscosity, it is preferably 1.62 or more and 1.70 or less, and more preferably 1.65 or more and 1.69 or less.
[0169] In addition, when used as an adhesive, the maximum indentation depth is preferably 10 μm to 70 μm, more preferably 15 μm to 50 μm, from the viewpoint that the cured product is soft and can easily follow the step difference of the adherend. In addition, from the viewpoint that the molecular mobility is large and the recovery is improved, the elastic deformation power is preferably 60% to 100%, more preferably 75% to 98%.
[0170] [Method for producing hardened product]
[0171] The method for manufacturing the cured product of the present embodiment is not particularly limited, and for example includes: a film forming step of forming a film of the active energy ray-curable composition of the present embodiment on a substrate; and a hardening step of irradiating the film of the active energy ray-curable composition obtained in the film forming step with active energy rays to cure it.
[0172] As a film forming method for a substrate such as a transparent film, a coating method can be cited. As a coating method, a known method can be used, for example, a method using a batch rod or a wire rod, or various coating methods such as a micro-gravure, a gravure, a mold, a curtain, a lip, a slit or a rotation can be used.
[0173] The method for producing the cured product according to the present embodiment is, for example, Figure 1 As shown, the active energy ray-curable composition of the present embodiment is applied to the release surface of one release sheet 2a (or 2b) to form a coating layer having a predetermined thickness. After the formed coating layer overlaps the release surface of the other release sheet 2b (or 2a), the coating layer is irradiated with active energy rays such as LED lights with a wavelength of 365nm to cure it, thereby forming a cured product 1.
[0174] As another example of manufacturing the cured product 1, a coating liquid of a solvent-free adhesive composition is applied to the release surface of one of the release sheets 2a (or 2b), and the solvent-free adhesive composition is cured by irradiating the release sheet with active energy rays to form the cured product 1, and then the release surface of the other release sheet 2b (or 2a) is overlapped with the cured product 1.
[0175] The active energy rays can be used without particular limitation as long as they are active energy rays that cause curing of the curable composition of the present invention, but ultraviolet rays are particularly preferably used.
[0176] As the source of ultraviolet rays, there are LED, fluorescent chemical lamp, black light, low-pressure mercury lamp, high-pressure mercury lamp, ultra-high-pressure mercury lamp, metal halide lamp, sunlight, etc. For example, an 80W high-pressure mercury lamp can be used.
[0177] The intensity of ultraviolet irradiation can be kept constant, or the physical properties after curing can be fine-tuned by changing the intensity during curing. For example, when using an 80W high-pressure mercury lamp in a nitrogen atmosphere, 0.5kJ / m 2 ~3.0kJ / m 2 The energy value of ultraviolet light.
[0178] As active energy rays, for example, visible light rays and electron beam-based active energy rays may be used in addition to ultraviolet rays.
[0179] (Optical Adhesive Sheet)
[0180] The optical adhesive sheet of this embodiment can be formed using the cured product of this embodiment. The optical adhesive sheet of this embodiment can also be used as an adhesive sheet for bonding display device components, for example.
[0181] The optical adhesive sheet of this embodiment can be disposed between display device components such as cover glass, metal mesh, polarizing plate, etc. The optical adhesive sheet of this embodiment has high light transmittance and high refractive index, so the refractive index difference with the components is small, thereby improving light extraction efficiency.
[0182] [Method for producing optical adhesive sheet]
[0183] The method for producing the optical adhesive sheet of the present embodiment is not particularly limited, and includes, for example, the steps of applying the active energy ray-curable composition of the present embodiment to the substrate, and irradiating the substrate with active energy rays such as ultraviolet rays to form a cured coating film.
[0184] The method for producing the optical adhesive sheet of this embodiment is, for example, Figure 1As shown, the active energy ray-curable composition of the present embodiment is applied to the release surface of one release sheet 2a (or 2b) to form a coating layer having a predetermined thickness. After the formed coating layer overlaps the release surface of the other release sheet 2b (or 2a), the coating layer is irradiated with active energy rays such as LED lights with a wavelength of 365nm to cure it, thereby forming an optical adhesive sheet 1.
[0185] As another manufacturing example of the optical adhesive sheet 1, a coating liquid of a solvent-free adhesive composition is coated on the release surface of one of the release sheets 2a (or 2b), and the solvent-free adhesive composition is cured by irradiating it with active energy rays to form the optical adhesive sheet 1, and then the release surface of another release sheet 2b (or 2a) is overlapped with the optical adhesive sheet 1.
[0186] [Example]
[0187] Hereinafter, the present invention will be described in more detail with reference to Examples, but the present invention is not limited thereto.
[0188] (raw material)
[0189] "Zirconium oxide": UEP-100 (manufactured by First Rare Earth Chemical Industry Co., Ltd.)
[0190] "Zirconium oxide nanoparticle dispersion": Zirconium oxide nanoparticle dispersion, Nippon Catalyst Manufacturing, ZIRCOSTAR (registered trademark) high refractive index nanoparticle ZP-153
[0191] “Dispersant (D)” (phosphate ester compound): Dispersant D-1 (a compound represented by the following structural formula (1))
[0192] [Chemistry 2]
[0193]
[0194] (Where R 1 is methyl, R 2 is an ethylene chain having 2 carbon atoms; x is 5, y is 2 (average value), and n is an integer from 1 to 3)
[0195] “Silane coupling agent (E)”: KBM-503 (manufactured by Shin-Etsu Chemical Co., Ltd., 3-(trimethoxysilyl)propyl methacrylate)
[0196] “(Meth)acrylate compound (B-1)”:
[0197] EO modified phenoxyethyl acrylate (n=4) (polymer Tg=-32°C), manufactured by MIWON SPECIALTY CHEMICAL CO., LTD.
[0198] 2-Ethylhexyl Acrylate (Polymer Tg = -70°C) Made by Mitsubishi Chemical
[0199] “(Meth)acrylate compound (B-2)”:
[0200] Phenoxybenzyl acrylate (polymer Tg = 8°C) manufactured by Green Chemical Co., Ltd.
[0201] Phenyl benzyl acrylate (polymer Tg = 40°C) manufactured by Shin-Nakamura Chemical
[0202] “Photopolymerization initiator (C)”: 2,4,6-trimethylbenzoyldiphenylphosphine oxide, trade name: Runtecure 1108 (manufactured by Runtec Chemical Co., Ltd.)
[0203] Diethylene glycol dibenzoate: Made by Tokyo Chemical Industry
[0204] <Liquid Refractive Index>
[0205] The active energy ray-curable composition was directly applied onto the prism of an Abbe refractometer and measured at 25° C. Measurement wavelength: 589 nm.
[0206] <Glass transition temperature (Tg)>
[0207] The active energy ray-curable resin composition was filled between two glass plates using a 125 μm thick polyethylene terephthalate (PET) film as a spacer, and then irradiated with 2000 mJ / cm2 of LED light with a wavelength of 365 nm. 2 The film was cured by ultraviolet rays, and then the glass plate on the opposite side to the irradiated surface was peeled off to prepare a flat film-like cured product with a thickness of 125 μm on the glass plate.
[0208] The flat film-like hardened product was peeled off from the glass substrate, and a DSC curve was measured by dynamic scanning calorimetry (DSC) using a differential scanning calorimeter (X-DSC7000, manufactured by Hitachi High-Tech Scientific Corporation).
[0209] Heating conditions: 20℃→80℃, 80℃→-50℃, -50℃→80℃ (10℃ / min) Atmosphere: N2
[0210] Plate: Al
[0211] <Film refractive index>
[0212] The active energy ray-curable composition was sandwiched between a glass plate and a transparent and easily adhesive PET film (trade name: A4300, thickness: 125 μm, manufactured by Toyobo) as a transparent substrate, and spread out to a film thickness of about 10 μm using a rubber hand roller, and then irradiated with active energy rays to cure. Next, the PET film and the active energy ray-curable resin layer were peeled off from the glass plate to form a cured coating film of the curable composition on the surface of the substrate. The refractive index of the coating film was measured using a PRISM COUPLER MODEL 2010 / M (manufactured by Metricon).
[0213] "Irradiation conditions"
[0214] Light source: Ultraviolet light from ultra-high pressure mercury lamp
[0215] Total light intensity: 400mJ / cm 2
[0216] "Measurement conditions"
[0217] Wavelength: 594nm
[0218] Measurement mode: single film
[0219] <Viscosity>
[0220] The viscosity was evaluated by measuring the viscosity at a temperature of 25° C. using an E-type rotational viscometer (“TVE-25H” manufactured by Toki Sangyo Co., Ltd.).
[0221] <Micro hardness>
[0222] A flat film-shaped hardened material with a glass substrate was prepared in the same manner as in the above <Glass transition temperature (Tg)>, except that a diamond flat indenter was used instead of a diamond quadrangular pyramid indenter, and the hardness was measured using a micro hardness tester (trade name HM2000) manufactured by Fischer Instruments Co., Ltd. in accordance with International Organization for Standardization (ISO) 14577-1. The test conditions are as follows.
[0223] Plane size of flat indenter: 100μm×100μm
[0224] Per second: 20mN~60mN
[0225] Maximum compression force: 500mN
[0226] Stop time at maximum compression force: 5 to 10 seconds
[0227] F: 500mN / 10s (maximum test force / time required to reach maximum test force)
[0228] C: 5.0s (maximum test force holding time)
[0229] R: 0.1mN / 10s (minimum test force / time required to unload the minimum test force)
[0230] C2: 10.0s (minimum test force holding time)
[0231] If Figure 2 By continuously monitoring the load and the penetration depth as shown in the simulation diagram, the parameters can be obtained as follows.
[0232] nIt:Elastic deformation power (=W elast / (W elast +W plast )×100)(Unit: %)
[0233] hmax u: Maximum indentation depth (unit: μm)
[0234] hp u: Permanent indentation depth after test force unloading (unit: μm)
[0235] CIT1: Indentation creep (=(h2-h1) / h1×100) (unit: %)
[0236] <Viscosity>
[0237] With respect to the flat film-like cured product with a glass substrate produced in the same manner as in the above <Glass transition temperature (Tg)>, after pressing a glass plate, only the upper glass plate pressed was lifted up, and the viscosity was determined as follows.
[0238] ○: The flat film-like cured product with the glass substrate on the lower side is lifted.
[0239] △: The flat film-like cured product with the glass substrate on the lower side was temporarily lifted, but immediately fell down.
[0240] ×: The flat film-like cured product with the glass substrate on the lower side could not be lifted up.
[0241] (Example 1)
[0242] 55.4 parts by mass of zirconium oxide nanoparticles (manufactured by Daiichi Kizenso Chemical Industry Co., Ltd., trade name: UEP-100) as inorganic oxide particles (A)
[0243] 8.3 parts by mass of phosphoric acid ester 1 (the compound represented by the structural formula (1)) as a dispersant (D),
[0244] 5.5 parts by mass of 3-(trimethoxysilyl)propyl methacrylate (manufactured by Shin-Etsu Chemical Co., Ltd., trade name: KBM-503) as a silane coupling agent (E) and 69.3 parts by mass of methyl ethylketone (hereinafter referred to as "MEK") as a solvent were mixed and roughly dispersed by stirring for 30 minutes using a dispersing mixer. Next, the obtained mixed solution was dispersed using a media wet disperser ("Star Mill LMZ-015" manufactured by Ashizawa Finetech Co., Ltd.) and zirconium oxide beads with a particle diameter of 100 μm. While confirming the particle diameter in the middle, the dispersion treatment was performed for a residence time of 100 minutes to obtain an inorganic particle dispersion.
[0245] 2.9 parts by mass of 2-ethylhexyl acrylate (polymer Tg = -70°C, manufactured by Mitsubishi Chemical) as (meth)acrylate (B-1) having a polymer Tg of -2°C or less and 19.0 parts by mass of phenoxybenzyl acrylate (polymer Tg = 8°C, manufactured by Green Chemical Co., Ltd.) as (meth)acrylate (B-2) having a polymer Tg of 0°C or more were added to the inorganic particle dispersion, and the volatile components were removed under reduced pressure while heating with an evaporator. Furthermore, 2.9 parts by mass of 2,4,6-trimethylbenzoyldiphenylphosphine oxide (manufactured by Runtec Chemical Co., Ltd., trade name: Runtecure 1108) as a photopolymerization initiator and 5.8 parts by mass of diethylene glycol dibenzoate (manufactured by Tokyo Chemical Industry) as an additive were added to prepare an active energy ray-curable composition P1 (composition P1) of the present embodiment. The liquid refractive index and viscosity of composition P1 were evaluated using the above evaluation method. In addition, the film refractive index, microhardness, and viscosity of the cured product of composition P1 were evaluated. These results are shown in Table 1.
[0246] (Examples 2 to 4, Example 6, Comparative Example 1, Comparative Example 3)
[0247] Each example uses the components and composition ratios shown in Table 1. In addition, the same method as in Example 1 was used to prepare compositions P2 to P4, P6, cP1, and cP3 of Examples 2 to 4, Example 6, Comparative Example 1, and Comparative Example 3, respectively. In addition, the amount of MEK used was 2.15 times the amount of the inorganic nanoparticles shown in Table 1, as in Example 1. The liquid refractive index and viscosity of each composition were evaluated in the same manner as in Example 1. In addition, the film refractive index, microhardness, and viscosity of the cured product of each composition were evaluated. These results are shown in Table 1.
[0248] (Example 5, Comparative Example 2)
[0249] Using zirconium oxide nanoparticle dispersion (ZIRCOSTAR (registered trademark) high refractive index nanoparticle ZP-153) manufactured by Japan Catalyst instead of the prepared inorganic particle dispersion, the composition P5 and composition cP2 of Example 5 and Comparative Example 2 were prepared in the same manner as in Example 1. In addition, the amount of MEK used was the same as in Example 1, which was 2.15 times the amount of inorganic nanoparticles shown in Table 1. The liquid refractive index and viscosity of each composition were evaluated in the same manner as in Example 1. In addition, the film refractive index, microhardness, and viscosity of the cured product of each composition were evaluated. These results are shown in Table 1.
[0250] [Table 1]
[0251]
[0252] (Inspection)
[0253] As shown in Table 1, in the examples, a high-refractive-index active energy ray-curable composition and a cured product thereof having viscosity even after curing are obtained. The reason is that by using zirconium oxide as inorganic particles with a high refractive index and (meth)acrylate (B-1) having a polymer Tg of -2°C or less, a low Tg of -2°C or less is obtained after curing, and a rubber state is maintained even at room temperature. Furthermore, by using (meth)acrylate (B-2) having a polymer Tg of 0°C or less, a high refractive index can be achieved while maintaining a certain viscosity for handling. In addition, in Comparative Examples 1, 2, and 3 that do not contain (meth)acrylate (B-1) having a polymer Tg of -2°C or less, the Tg after curing is above 0°C, and good viscosity cannot be obtained. In addition, as shown in Table 1, in the examples, the maximum indentation depth is set to 10 μm or more and the elastic deformation power is set to 60% or more, thereby obtaining good viscosity. The reason is that the maximum indentation depth is large, the cured product is soft, and follows the unevenness of the glass surface as the adherend. Furthermore, by setting the maximum indentation depth to 15 μm or more and the elastic deformation power to 75% or more, better viscosity was obtained. On the other hand, in Comparative Examples 1, 2, and 3 where the maximum indentation depth was less than 10 μm or the elastic deformation power was less than 60%, good viscosity could not be obtained.
Claims
1. An active energy ray-curable composition comprising inorganic oxide particles (A) and (meth)acrylate (B), The active energy ray-curable composition has a refractive index of 1.6 or more, The active energy ray-curable composition has a cured product having a glass transition temperature Tg of -2°C or less. 2 . The active energy ray-curable composition according to claim 1 , further comprising a photopolymerization initiator (C). 3 . The active energy ray-curable composition according to claim 1 , wherein the inorganic oxide particles (A) are zirconium oxide particles. 4 . The active energy ray-curable composition according to claim 1 , wherein the (meth)acrylate (B) comprises a (meth)acrylate (B-1) having a polymer Tg of −2° C. or less.
5. The active energy ray-curable composition according to claim 4, wherein the (meth)acrylate (B) comprises at least two (meth)acrylates, The two (meth)acrylates further include a (meth)acrylate (B-2) of a different kind from the (meth)acrylate (B-1). 6 . The active energy ray-curable composition according to claim 1 , further comprising a dispersant (D). 7 . The active energy ray-curable composition according to claim 6 , wherein the dispersant (D) comprises a phosphoric acid ester compound. 8 . The active energy ray-curable composition according to claim 1 , wherein a cured product of the active energy ray-curable composition has a glass transition temperature Tg of −5° C. or less. 9 . The active energy ray-curable composition according to claim 1 , wherein the active energy ray-curable composition is used for an optical adhesive sheet. 10 . A cured product, which is a cured product of the active energy ray-curable composition according to claim 1 , wherein the cured product has a glass transition temperature Tg of −2° C. or less. An optical adhesive sheet comprising the cured product according to claim 10 .
